Cinical trials:

Various randomized multicentre international phase III clinical trials and randomized bioequivalence studies

Memberships:

1. Multinational association for supportive care in cancer (MASCC)
2. European Society for Medical Oncology (ESMO)
3. Serbian Medical Society-general secretary
4. Serbian Society of Medical Oncology
5. European Association for Cancer Research (EACR)
6. Serbian Association for Cancer Research (SDIR)
7. Society of Hematologic Oncology (SOHO) – Ambassador to Serbia

Publications:

I Abstracts from International congresses /Abstract Books/:
1. Nikolić V, Josifovski J, Radosavljević D, Nikolić N, Ristić M, Djordjević F, Čavić M, Jakovljević K, Janković R, Gavrilović D:
Efficasy of the combination of Irinotecan and Cetuximab in treating patients with chemotherapy refractory metastatic colorectal cancer- preliminary results- Arch.of Gastroenterohepatology, oct 2011,Vol.28, No1-2,p.104,PP32

2. Spasić J, Krivokuća, A, Čavić, M, Jakovljević, K, Mališić E, Ristić, M, Djordjević F, Radosavljević D, Janković R.
Thymidylate synthase gene polymorphisms and lung adenocarcinoma in Serbia. 3rd European Lung Cancer Conference. J Thorac Oncol. 2012,7(6), Supplement 1:S42 (abstract id. 113P)

3. Spasić J, Stanic N, Djordjević F, Ristić M, Nikolić N, Radosavljević D.
Is there an association between the occurrence of neutropenia and neuropathy in patients with metastatic colorectal cancer treated with Folfox Ann Oncol (2013) 24 (suppl 4): iv97

4. J.Dimitrijevic , S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic. The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients admitted to Clinic for medical oncology, Instutute for oncology and radiology of Serbia. 2nd Regional Congress on Supportive Care in Oncology. Abstract book (2014)

5. Djordjevic F, Bosnjak S, Dimitrijevic J, Stanic N, Bakic N, Susnjar S. Hydromorphone SR effective and safe for the treatment of cancer dyspnea in lung cancer patients: positive preliminary results. Support Care Cancer 2015, 23 (Suppl 1): S260

6. Spasic J, Stanic,N, Ristic M, Djordjevic F , Nikolic N, Nikolic V, Pupovac S, Radosavljevic,D. (2015). Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia. Annals of Oncology. 26. 10.1093/annonc/mdv233.276.

7. Bosnjak S, Dimitrijevic J, Djordjevic F. Cancer and Chemotherapy-induced Nausea and Vomiting: A focus on olanzapine. Current Opinion in Supportive & Palliative Care (2016), 10:180–188

8. Scientific Days of the Oncology Institute, May 2017,Bucharest, Romania- abstract book: F.Djordjevic. Serbian model of integration of Palliative care into Oncology practice

9. Spasic J, Stanic N, Djordjevic F , Ristic M, Nikolić V, Radosavljevic, Davorin. (2017). Mitomycin-c (mtc) as salvage therapy for patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 28. 10.1093/annonc/mdx261.321

10. Spasic, J,Stanic, N, Djordjevic F, Jokic V Radosavljevic D (2018). P3.01-92 Blood Test Parameters as Prognostic Factors In EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs. Journal of Thoracic Oncology. 13. S902. 10.1016/j.jtho.2018.08.1652.

11. Radosavljevic D, Spasic J, Ristic M , Nikolic V , Nikolic N, Stanic, N. , Djordjevic F, Gavrilović, Dušica. (2018). P3.01-85 Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations – Serbian Single Center Experience. Journal of Thoracic Oncology. 13. S899. 10.1016/j.jtho.2018.08.1645.

12. Djordjevic F. Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) (2018) Clinical Lymphoma, Myeloma and Leukemia, Volume 18, S238

II Abstracts from National congresses /Abstract Books/:
1. Section of oncology of Serbian Medical Society 52 th annual meeting, abstract book: F.Djordjevic. Dyspnea in advanced cancer patients: ESMO Clinical Practice Guidelines (2015)

2. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Dyspnea in patients with lung cancer (2016)

3. 7th Serbian-French Oncology Congress, March 2016 Novi Sad, Serbia- abstract book: Morphine: Cancer Pain and Dyspnoea

4. Section of oncology of Serbian Medical Society 53 th annual meeting, abstract book: J.Dimitrijevic, S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic.The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients with melanoma admitted to Clinic for medical oncology (CMO), Instutute for oncology and radiology of Serbia (IORS) (2016)

5. Section of oncology of Serbian Medical Society 54 th annual meeting, Belgrade, Serbia, November 2017- abstract book: Djordjevic F, Stanic N, Dimitrijevic J, Spasic J, Zilic A, Bosnjak S, Radosavljevic D, Susnjar S. The efficacy and tolerability of slow release hydromorphone in the treatment of cancer dyspnea in lung cancer patients: experience from the Institute for Oncology and Radiology of Serbia

6. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Immunotherapy in the first line treatment in patient with NSCLC (2018)

III Books and Monographies/Brochures:

1. Educational brochure for patients about prevention and therapy of chemotherapy induced nausea and vomiting for Serbian Society for the Fight Against Cancer (2015)

2. Educational brochure for patients about supportive oncology for Institute for oncology and radiology of Serbia (2015)

Lectures at European meetings:

Lecturer at the 11th European Congress on Public Health in Ljubljana on November 30, 2018. Title: “The role of a Cancer Control Plan in Advancing Patient Outcomes”

Lecturer by invitation at the meeting Cost Action CA17404 “New diagnostic and therapeutic tools against multidrug resistant tumors” Belgrade, 27/28.02.2020. Title: “Targeted therapies in oncology – advantage and resistance”

Professional work in expert commissions and associations in Serbia:

For the National Guide for the Diagnosis and Treatment of Lung Cancer 2011. wrote a chapter on chemotherapy for advanced non-small cell lung cancer. For the 2012 National Guide for the Treatment and Diagnosis of Colon and Rectal Cancer. wrote a chapter on adjuvant and systemic chemotherapy for colorectal cancer.

President of the Subcommittee for Antineoplastic Medicines of the Central Committee for Medicines of the RFZO 2004-2012.

Member of the Republic Expert Commission for Oncology since 2014. and the Republican Expert Commission for Cytotoxic and Molecularly Targeted Medicines of the Ministry of Health 2015-2019. Previously, a member of the Subcommittee for Medicines of the RSK for oncology since 2008. ALIMS external expert since 2004.

Vice President of the Central Commission for Medicines of the RFZO from 2021.

Memberships in professional associations:

Member of the SLD Cancer Section since 1986. secretary of the Section 1995-2001, member of the Presidency.
Member of the Presidency of the Association of Medical Oncologists of Serbia (UMOS) since its foundation in 2005.
Member of the European Association of Medical Oncologists (ESMO) since 1996. and the American Society of Clinical Oncologists (ASCO) since 2003.
Member of the Balkan Union of Oncologists (BUON) since 1996, member of the Editorial Board of J of BUON.
Member of the Central European Cooperative Oncology Group (CECOG) since 2004

PUBLICATIONS AND MEMBERSHIPS:

• 2005 DSZBPR brochure – Nutrition in cancer patients
• 2022 Magazine “RAK” – Stereotaxic radiotherapy
• 2023 EANS2023 Barcelona – Gamma knife treatments of recurrent metastases after previous conducted palliative radiotherapy of the whole brain
• Member of the Serbian Medical Association and the European Association of Neurosurgeons (EANS)

AREA OF INTEREST:
Radioneurosurgery

Work experience:

• Since 1999, medical oncologist, Institute of Oncology and Radiology of Serbia, Clinic for Medical Oncology, Department of Breast Cancer and Gynecology

Dr Božović-Spasojević is the founder of the academic group for breast cancer research in Serbia. And leads the research program on breast cancer in men in Serbia within the EORTC (European Organization for Research and Treatment of Cancer) organization; participates in the fertility preservation and pregnancy planning program for patients with breast cancer, within the framework of fertility preservation counseling.

She is one of the authors of the national guide for the treatment of breast cancer, as well as the author of a clinical oncology textbook for students of the Faculty of Medicine in Belgrade. She has written numerous brochures for patients being treated for malignant diseases. Dr Božović-Spasojević has participated in the leadership program within the European Association of Medical Oncologists, ESMO Leaders Generation Program 2018. She graduated from the Academy for Health Management in Serbia, Methodes doo, FranklinCovey USA in 2017. She is a member of the Central Ethics Committee of Serbia, a member of the working group for oncology at the Ministry of Health in the period from 2015 to 2020. She is also a member of the board of directors of the National Association of Medical Oncologists of Serbia, UMOS; head of the working group for the treatment of malignant diseases in young people at the European Society for Medical Oncologists (ESMO).